GMEDGlobus Medical

Median target
$115
calls from the last 12 months
Implied return
+55.1%
median target vs. price
Coverage
16 analysts · 16 calls
updated in the last 12 months
Consensus
13/3/0+13 net
Buy / Hold / Sell

Which analysts are behind GMED's consensus?

See every current rating, price target and the analysts' track records for Globus Medical — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 16 analysts with calls on GMED updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

GMED elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-15InsidersTobin James RDirectorInsider sale30.0K sh @ $74.58$2.2M
2026-08-19CongressGilbert CisnerosCA-CA39Purchasesince trade -16.1%, vs market -15.2%$15K–$50K
2026-08-18InsidersZarrilli Stephen TDirectorInsider sale25.0K sh @ $87.04$2.2M
2026-03-03CongressGilbert CisnerosCA-CA39Purchasesince trade -19.2%, vs market -31.5%$1K–$15K
2025-06-24CongressLisa McClainMI-MI09Salesince trade +26.3%, vs market +0.3%$1K–$15K
2025-05-23ExecutiveTrump, Donald JPresidentPurchaseGlobus Medical Inc$1,001 - $150,005
2025-05-05ExecutiveTrump, Donald JPresidentSaleGlobus Medical Inc$15,001 - $500,005
2025-04-04ExecutiveTrump, Donald JPresidentPurchaseGlobus Medical Inc$15,001 - $500,004
2023-04-03CongressJosh GottheimerNJ-NJ05Purchasesince trade +30.2%, vs market -62.4%$1K–$15K
2023-03-06CongressDaniel GoldmanNY-NY10Salesince trade +25.1%, vs market +71.3%$15K–$50K

More: congressional trades on GMED · insider activity · executive branch · trending